Advanced search
Publication Cover
Clinical Pharmacology: Advances and Applications Volume 15, 2023 - Issue
Submit an article Journal homepage
189
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Ipratropium Bromide/Salbutamol-Induced Acute Urinary Retention as a Result of Medication Error: A Case Report and Review of Cases in the Literature

Mohammed Abdullah Kubas1 Department of Clinical Pharmacy and Pharmacy Practice, University of Science and Technology, Sana’a, Yemen;2 Clinical Pharmacy Department, University of Science and Technology Hospital (USTH), Sana’a, YemenORCID Iconhttps://orcid.org/0000-0002-6031-2634
ORCID Icon,
Fahmi Y Al-Ashwal1 Department of Clinical Pharmacy and Pharmacy Practice, University of Science and Technology, Sana’a, Yemen;3 Department of Clinical Pharmacy, College of Pharmacy, Al-Ayen University, Thi-Qar, IraqCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2076-0771
ORCID Icon,
Orwa Khaled Babattah‎4 Urology Department, University of Science and Technology Hospital (USTH), Sana’a, Yemen
&
Akram Ameen Alsaqqaf‎4 Urology Department, University of Science and Technology Hospital (USTH), Sana’a, Yemen
Pages 107-111 | Received 30 Jul 2023, Accepted 16 Nov 2023, Published online: 20 Nov 2023

References

  • Aronson JK. Medication errors: what they are, how they happen, and how to avoid them. QJM. 2009;102(8):513–521. doi:10.1093/qjmed/hcp052
  • Cousins D, Sabatier B, Begue D, Schmitt C, Hoppe-Tichy T. Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France. BMJ Qual Saf. 2005;14(3):190–195. doi:10.1136/qshc.2003.006676
  • Verhamme KM, Sturkenboom MC, Stricker BHC, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Safety. 2008;31(5):373–388. doi:10.2165/00002018-200831050-00002
  • Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):643–650.
  • Loke YK, Singh S. Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review. Therap Adv Drug Safety. 2013;4(1):19–26. doi:10.1177/2042098612472928
  • Afonso A, Verhamme K, Stricker B, Sturkenboom M, Brusselle G. Inhaled anticholinergic drugs and risk of acute urinary retention. BJU Int. 2010;107(8):1265–1272. doi:10.1111/j.1464-410X.2010.09600.x
  • Hooimeijer H, Van Der Deure J, de Langen J. Voiding difficulties in a child attributed to the use of ipratropium and salbutamol. Ned Tijdschr Geneeskd. 2007;151(49):2726–2728.
  • Lozewicz S. Bladder outflow obstruction induced by ipratropium bromide. Postgrad Med J. 1989;65(762):260–261. doi:10.1136/pgmj.65.762.260
  • Boehringer Ingelheim Pharmaceuticals. Combivent® (ipratropium bromide and albuterol sulfate). Prescribing information. [package insert]. The USA: Food and Drug Administration. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020291s031lbl.pdf. Accessed November 16, 2023.
  • Serlin DC, Heidelbaugh JJ, Stoffel JT. Urinary retention in adults: evaluation and initial management. Am Fam Physician. 2018;98(8):496–503.
  • Pras E, Stienlauf S, Pinkhas J, Sidi Y. Urinary retention associated with ipratropium bromide. DICP. 1991;25(9):939–940. doi:10.1177/106002809102500907
  • D’Auria E, Mandelli M, Di Dio F, Riva E. Urine retention in a child treated with oral salbutamol. Indian J Pharmacol. 2012;44(4):519. doi:10.4103/0253-7613.99338

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.